Topic resource collection
Approved comparison material connected to this topic.
3 resourcesRead both sides
This table compares the three primary peptides used in clinical CIRS protocols, their mechanisms, dosing, and application timing. Thymosin Alpha-1 Modulates T-cell differentiation; reduces IL-6, TNF-alpha 0.9–1.6mg subcutaneous, …
Thymalin Restores thymic epithelial function and T-cell differentiation Thymus, immune system 10mg SC daily × 10 days 4–6 weeks for normalised CD4/CD8 First-line for immune dysregulation. Addresses root cause of autoimmune-like s…
VIP (Vasoactive Intestinal Peptide) Neuropeptide restoration, cytokine modulation TNF-alpha, IL-6 inhibition; IL-10 upregulation; VIP receptor signaling Intranasal 50–200 mcg/day (divided doses) VCS normalization, shortness of br…